Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion.The transaction has received all necessary regulatory approvals.The Transfusion
/PRNewswire/ Werfen announced today that it has agreed to acquire Immucor, Inc., from TPG. Immucor is a privately held corporation with a strong global.